草酸铂联合羟基喜树碱、氟尿嘧啶、甲酰四氢叶酸钙治疗晚期胃癌
出处
《临床肿瘤学杂志》
CAS
2006年第3期223-225,共3页
Chinese Clinical Oncology
参考文献3
-
1王竞,王金万.胃癌治疗进展[J].癌症进展,2004,2(2):88-93. 被引量：37
-
2Raymond E,Chaney SG,Taama A,et al.Oxaliplatin a review of preclinical and clinical studies[J].Ann Oncol,1998,9 (10):1053-1071.
-
3沈琳,李洁,张晓东,李燕,张小田,金懋林.PELF方案治疗进展期胃癌68例[J].中国肿瘤临床,2005,32(3):162-164. 被引量：19
二级参考文献34
-
1[1]Alberts SR, Cervantes A, van de Velde CJH. Gastric cancer:Epidemiology, pathology and treatment. Annals of Oncology,2003, 14 (Suppl 2) :ii31
-
2[2]Frederick LG, David LP, Irvin DF, et al. AJCC Cancer Staging Manual. 6th. ed, New York: Springer, 2002, 99
-
3[3]Hundahl SA, Menck HR, Mansour EG, et al. The national cancer database report on gastric carcinoma. Cancer, 1997, 80: 2333
-
4[4]Spataro V, Genoni M, Maurer C, et al. Stomach cancer: 10years' experience with surgical treatment and possibilities for improving the prognosis. Helv Chir Acta, 1993, 59:589
-
5[5]Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med, 2001, 345:725
-
6[6]Bajetta E, Buzzoni R, Mariani E, et al. Adjuvant chemotherapy in gastric cancer: 5 - year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group. Annals of Oncology, 2002, 13:299
-
7[7]Falcone A. Future strategies and adjuvant treatment of gastric cancer. Annals of Oncology, 2003, 14 (Suppl 2) :ii45
-
8[8]Roth AD, Allal AS, Brundler MA, et al. Neoadjuvant radiochemotherapy for locally advanced gastric cancer: A phase Ⅰ -Ⅱ study. Annals of Oncology, 2003, 14:110
-
9[9]Newman E, Marcus SG, Potmesil M, et al. Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer. J Gastrointest Surg, 2002 6 (2) :212 (discussion 223)
-
10[10]Gimelius B, Ekstrom K, Hoffman K, et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Annals of Oncology, 1997, 8:1
共引文献54
-
1邓立春,蔡洪川,姜藻,张瑶,沈伟生,袁明,奚蕾.奥沙利铂联合表阿霉素和氟尿嘧啶治疗晚期胃癌的临床观察[J].现代医学,2008,36(4):268-269. 被引量：4
-
2沈琳,金懋林,张晓东,李洁,刘庆森,胡国清,吴晴,付强,陆震宇,李杰.澳沙利铂联合表阿霉素5-FU/CF治疗晚期胃癌的临床探讨[J].中国肿瘤临床,2005,32(8):472-475. 被引量：13
-
3王达,陈树泉.中药康艾注射液联合化疗治疗胃癌的临床观察[J].临床医药实践,2005,14(5):369-369. 被引量：3
-
4林汉昇,徐达元,何应新.胃癌急性穿孔的诊断与治疗[J].黑龙江医学,2005,29(7):494-495.
-
5任海华,毕文,高贤鲁.草酸铂为主联合化疗治疗晚期胃肠道肿瘤54例疗效观察[J].肿瘤防治杂志,2005,12(18):1419-1420. 被引量：2
-
6段仁慧,孙晓琴,赵九红.OHLF3方案治疗晚期胃癌的临床观察[J].肿瘤防治杂志,2005,12(15):1180-1182. 被引量：3
-
7张宇.国产奥沙利铂联合亚叶酸钙和氟氯嘧啶治疗进展期胃癌的疗效观察[J].青海医药杂志,2005,35(11):34-35.
-
8任铁军,尹峰.3种药物联合治疗晚期胃癌的近期疗效和不良反应[J].现代预防医学,2006,33(1):119-119.
-
9任大成,李光明,付曦,郭翠华,文仕民,潘永强,胡欣,别俊,孙永红.小剂量顺铂联合变异LV5FU2治疗进展期胃癌的临床观察[J].华西医学,2006,21(1):143-144.
-
10吴萍,王理伟,周翡,刘全珍.含草酸铂和含表阿霉素联合方案治疗晚期胃癌的临床观察[J].中华肿瘤防治杂志,2006,13(1):58-60. 被引量：18
-
1王璋,吴泉峰.OHLF3方案联合贝伐单抗治疗晚期胃癌临床疗效及安全性研究[J].中国临床研究,2016,29(3):379-380. 被引量：4
-
2刘德玲,吴田,张雪玲.贝伐单抗联合OHLF3方案治疗晚期胃癌疗效观察[J].中国保健营养（下半月）,2013,0(4):836-836. 被引量：4
-
3冯秀琴,何惠.联合贝伐单抗治疗晚期胃癌患者临床疗效及对各血清肿瘤标志物水平的影响[J].宁夏医学杂志,2017,39(2):121-123. 被引量：5
-
4王连胜,周亚元.胃癌病例7年变化对比分析[J].中国冶金工业医学杂志,2004,21(3):205-206.
-
5Suzanne A Eccles,Danny R Welch,肖远（译）.癌症转移的近期发现与新治疗策略[J].世界临床医学,2008,2(1):58-74.
-
6吴田,黄启标,陈桂民.OHLF_3和FOLFOX_4方案治疗晚期胃癌疗效观察[J].实用癌症杂志,2006,21(4):387-389.
-
7胡国清,付强,金懋林,沈琳,李杰,潘良熹,白玉贤,王怀瑾,张健伟,于丁.草酸铂联合羟基喜树碱、氟脲嘧啶、甲酰四氢叶酸钙治疗晚期胃癌36例的疗效观察[J].中国肿瘤临床,2004,31(9):506-508. 被引量：4
-
8颜培平,周传骥.肺内X线所见播散病变的鉴别诊断[J].中国社区医师（医学专业）,2005,7(3):52-53.
-
9陈克能,顾振东,徐光炜.肺转移癌的治疗进展[J].中华外科杂志,2004,42(8):489-491. 被引量：1
-
10马宁,周云.贝伐单抗联合OHLF3方案治疗晚期胃癌疗效观察[J].中国实用医药,2014,9(29):175-176. 被引量：2
